Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Ketamine Analgesia in Third Molar Surgery
NCT04459377Phase 4Completed
- Sponsor
- Region Dalarna
- Start
- Feb 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by Region Dalarna. Primary endpoint: Visual Analog Scale (VAS) for Pain. Started Feb 2017; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04459377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459377.